FOX
50
2
GOOG
75
2
CAH
43
2
DG
36
-2
AVGO
57
-4
XEL
60
-2
JPM
71
2
ECL
84
2
IRM
71
-2
FSLR
76
3
EQT
57
3
OI
39
-4
EBAY
43
-2
MU
56
-3
AAP
27
3
BIIB
45
-3
CHRW
56
2
AA
53
5
SLB
46
2
HPE
44
-2
FOX
50
2
GOOG
75
2
CAH
43
2
DG
36
-2
AVGO
57
-4
XEL
60
-2
JPM
71
2
ECL
84
2
IRM
71
-2
FSLR
76
3
EQT
57
3
OI
39
-4
EBAY
43
-2
MU
56
-3
AAP
27
3
BIIB
45
-3
CHRW
56
2
AA
53
5
SLB
46
2
HPE
44
-2
Financhill
Back

Takeda Pharmaceutical Vs. Astellas Pharma Industry Stock Comparison

Sell
24

TAK
Takeda Pharmaceutical

Last Price:
13.23
Seasonality Move:
1.23%
Sell
23

ALPMY
Astellas Pharma

Last Price:
9.48
Seasonality Move:
5.62%
Sell
24
Takeda Pharmaceutical (TAK) is a Sell

Is Takeda Pharmaceutical a Buy, Sell or Hold?

  • The current Takeda Pharmaceutical [TAK] share price is $13.22. The Score for TAK is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • TAK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Astellas Pharma (ALPMY) is a Sell

Is Astellas Pharma a Buy, Sell or Hold?

  • The current Astellas Pharma [ALPMY] share price is $9.48. The Score for ALPMY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALPMY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TAK Stock Price Chart

What is Takeda Pharmaceutical's stock price today?

  • The Takeda Pharmaceutical share price today is $13.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TAK is experiencing selling pressure, which indicates risk of future bearish movement.

ALPMY Stock Price Chart

What is Astellas Pharma's stock price today?

  • The Astellas Pharma share price today is $9.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMY is experiencing selling pressure, which indicates risk of future bearish movement.

TAK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 45.48 Sell
Chaikin Money Flow: -721219 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.13 - 13.35) Sell
Bollinger Bands (100): (13.48 - 14.72) Sell

ALPMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 36.29 Sell
Chaikin Money Flow: -109335 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.44 - 9.88) Sell
Bollinger Bands (100): (9.98 - 11.6) Sell

TAK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.27 Sell
20-day SMA: 13.25 Sell
50-day SMA: 13.65 Sell
200-day SMA: 14.42 Sell
8-day EMA: 13.28 Sell
20-day EMA: 13.31 Sell
50-day EMA: 13.58 Sell
200-day EMA: 14.31 Sell

ALPMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.73 Sell
20-day SMA: 9.72 Sell
50-day SMA: 10.18 Sell
200-day SMA: 12.09 Sell
8-day EMA: 9.7 Sell
20-day EMA: 9.79 Sell
50-day EMA: 10.13 Sell
200-day EMA: 11.75 Sell

Takeda Pharmaceutical Earnings Growth & TAK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Astellas Pharma Earnings Growth & ALPMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Takeda Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Astellas Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):